Our Science – Pastan Website
Ira Pastan, M.D.
Selected Publications |
 |
| 1)
Wei H, Bera TK, Wayne AS, Xiang L, Colantonio S, Chertov O, Pastan I. A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with Deletion of WDR85. J. Biol. Chem. [Epub ahead of print], 2013. [Journal] |
|
| 2)
Weldon JE, Xiang L, Zhang J, Beers R, Walker DA, Onda M, Hassan R, Pastan I. A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity. Mol. Cancer Ther. 12: 48-57, 2013. [Journal] |
|
| 3)
Ueno T, Kobayashi N, Nakayama M, Takashima Y, Ohse T, Pastan I, Pippin JW, Shankland SJ, Uesugi N, Matsusaka T, Nagata M. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int. [Epub ahead of print], 2013. [Journal] |
|
| 4)
Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood. 121: 1165-74, 2013. [Journal] |
|
| 5)
Yamaguchi T, Danjo T, Pastan I, Hikida T, Nakanishi S. Distinct Roles of Segregated Transmission of the Septo-Habenular Pathway in Anxiety and Fear. Neuron. [Epub ahead of print], 2013. [Journal] |
|
| 6)
Chandramohan V, Bao X, Kato Kaneko M, Kato Y, Keir ST, Szafranski SE, Kuan CT, Pastan IH, Bigner DD. Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors. Int. J. Cancer. 132: 2339-48, 2013. [Journal] |
|
| 7)
Choi BD, Kuan CT, Cai M, Archer GE, Mitchell DA, Gedeon PC, Sanchez-Perez L, Pastan I, Bigner DD, Sampson JH. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Proc. Natl. Acad. Sci. U.S.A. 110: 270-5, 2013. [Journal] |
|
| 8)
Liu XF, Fitzgerald DJ, Pastan I. The insulin receptor negatively regulates the action of pseudomonas toxin-based immunotoxins and native pseudomonas toxin. Cancer Res. 73: 2281-8, 2013. [Journal] |
|
| 9)
Liu W, Onda M, Kim C, Xiang L, Weldon JE, Lee B, Pastan I. A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity. Protein Eng. Des. Sel. 25: 1-6, 2012. [Journal] |
|
| 10)
Liu XF, Bera TK, Kahue C, Escobar T, Fei Z, Raciti GA, Pastan I. ANKRD26 and Its Interacting Partners TRIO, GPS2, HMMR and DIPA Regulate Adipogenesis in 3T3-L1 Cells. PLoS ONE. 7: e38130, 2012. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/26/2013.
